

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29631418 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29631418 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.26663851 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26663851 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22474902 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.22474902 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22474902 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22474902 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22474902 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.22474902 |
| 11 | detection of other organism (GO:0098543) | 4.05157946 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 3.99234037 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95411354 |
| 14 | detection of bacterium (GO:0016045) | 3.82296461 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 3.77710735 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71184063 |
| 17 | detection of external biotic stimulus (GO:0098581) | 3.64948685 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61939687 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59622220 |
| 20 | germinal center formation (GO:0002467) | 3.55464778 |
| 21 | regulation of cholesterol storage (GO:0010885) | 3.51954551 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40045945 |
| 23 | low-density lipoprotein particle clearance (GO:0034383) | 3.30302809 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24993775 |
| 25 | leukocyte aggregation (GO:0070486) | 3.23656575 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.21328273 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 3.20577673 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16460804 |
| 29 | detection of biotic stimulus (GO:0009595) | 3.15650890 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.15352029 |
| 31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05352145 |
| 32 | cellular extravasation (GO:0045123) | 3.05003958 |
| 33 | response to type I interferon (GO:0034340) | 3.04106263 |
| 34 | positive regulation of interferon-beta production (GO:0032728) | 3.03816635 |
| 35 | defense response to protozoan (GO:0042832) | 3.03079618 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.00916055 |
| 37 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00410568 |
| 38 | type I interferon signaling pathway (GO:0060337) | 2.99198524 |
| 39 | cellular response to type I interferon (GO:0071357) | 2.99198524 |
| 40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.99168509 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98584197 |
| 42 | cellular response to interferon-alpha (GO:0035457) | 2.98168483 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.97733613 |
| 44 | protein carboxylation (GO:0018214) | 2.96833378 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.96833378 |
| 46 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94468254 |
| 47 | negative regulation of viral genome replication (GO:0045071) | 2.93667633 |
| 48 | T-helper 1 type immune response (GO:0042088) | 2.92802053 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 2.92777907 |
| 50 | granulocyte activation (GO:0036230) | 2.92509105 |
| 51 | response to protozoan (GO:0001562) | 2.92013996 |
| 52 | macrophage activation (GO:0042116) | 2.91119795 |
| 53 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.91047180 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 2.90452383 |
| 55 | neutrophil activation (GO:0042119) | 2.87882282 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87553758 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85911178 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83823176 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 2.83409276 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83170172 |
| 61 | positive regulation of type 2 immune response (GO:0002830) | 2.81924751 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 2.81916960 |
| 63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81913356 |
| 64 | regulation of necroptotic process (GO:0060544) | 2.80696384 |
| 65 | urea cycle (GO:0000050) | 2.80321070 |
| 66 | urea metabolic process (GO:0019627) | 2.80321070 |
| 67 | response to host immune response (GO:0052572) | 2.79599873 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79599873 |
| 69 | complement activation, alternative pathway (GO:0006957) | 2.78714975 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 2.78230085 |
| 71 | phospholipid efflux (GO:0033700) | 2.77027734 |
| 72 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76671098 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 2.74864438 |
| 74 | response to interferon-alpha (GO:0035455) | 2.72286559 |
| 75 | interferon-gamma secretion (GO:0072643) | 2.72183925 |
| 76 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71244337 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.71026601 |
| 78 | phospholipid homeostasis (GO:0055091) | 2.70856762 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70699952 |
| 80 | response to interleukin-15 (GO:0070672) | 2.69932970 |
| 81 | response to peptidoglycan (GO:0032494) | 2.68888814 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68153638 |
| 83 | regulation of type 2 immune response (GO:0002828) | 2.67852706 |
| 84 | protein localization to endosome (GO:0036010) | 2.67353253 |
| 85 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.66518666 |
| 86 | B cell mediated immunity (GO:0019724) | 2.65628033 |
| 87 | microglial cell activation (GO:0001774) | 2.65230030 |
| 88 | cellular response to virus (GO:0098586) | 2.64322802 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63611071 |
| 90 | T cell migration (GO:0072678) | 2.62679586 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 2.61650800 |
| 92 | negative regulation of type 2 immune response (GO:0002829) | 2.61533766 |
| 93 | negative regulation of lipid storage (GO:0010888) | 2.60430897 |
| 94 | regulation of mast cell degranulation (GO:0043304) | 2.59303060 |
| 95 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.59223317 |
| 96 | regulation of T cell tolerance induction (GO:0002664) | 2.59098281 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58310070 |
| 98 | high-density lipoprotein particle remodeling (GO:0034375) | 2.58141987 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58113595 |
| 100 | response to host (GO:0075136) | 2.58113595 |
| 101 | response to host defenses (GO:0052200) | 2.58113595 |
| 102 | positive regulation of lipid storage (GO:0010884) | 2.56682731 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56035964 |
| 104 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54842873 |
| 105 | myeloid dendritic cell activation (GO:0001773) | 2.54638807 |
| 106 | B cell receptor signaling pathway (GO:0050853) | 2.51656777 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51062304 |
| 108 | kynurenine metabolic process (GO:0070189) | 2.50254997 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 2.49704619 |
| 110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49365595 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 2.49237385 |
| 112 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49130464 |
| 113 | cellular response to interferon-gamma (GO:0071346) | 2.49059180 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49045953 |
| 115 | alpha-linolenic acid metabolic process (GO:0036109) | 2.48951066 |
| 116 | indole-containing compound catabolic process (GO:0042436) | 2.48809019 |
| 117 | indolalkylamine catabolic process (GO:0046218) | 2.48809019 |
| 118 | tryptophan catabolic process (GO:0006569) | 2.48809019 |
| 119 | nitrogen cycle metabolic process (GO:0071941) | 2.48179694 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 2.47772167 |
| 121 | regulation of protein activation cascade (GO:2000257) | 2.47295477 |
| 122 | cysteine metabolic process (GO:0006534) | 2.47187417 |
| 123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.47111216 |
| 124 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.46783603 |
| 125 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.45667969 |
| 126 | reverse cholesterol transport (GO:0043691) | 2.45657235 |
| 127 | homocysteine metabolic process (GO:0050667) | 2.44995580 |
| 128 | negative regulation of cholesterol transport (GO:0032375) | 2.44976100 |
| 129 | negative regulation of sterol transport (GO:0032372) | 2.44976100 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.44969110 |
| 131 | aromatic amino acid family catabolic process (GO:0009074) | 2.44855642 |
| 132 | regulation of interferon-beta production (GO:0032648) | 2.44149379 |
| 133 | tryptophan metabolic process (GO:0006568) | 2.43132824 |
| 134 | pinocytosis (GO:0006907) | 2.41215423 |
| 135 | I-kappaB phosphorylation (GO:0007252) | 2.40735421 |
| 136 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.40396654 |
| 137 | negative regulation of fibrinolysis (GO:0051918) | 2.37908909 |
| 138 | L-phenylalanine metabolic process (GO:0006558) | 2.37680163 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37680163 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37384554 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.37361264 |
| 142 | regulation of superoxide anion generation (GO:0032928) | 2.36944033 |
| 143 | regulation of complement activation (GO:0030449) | 2.36026070 |
| 144 | L-phenylalanine catabolic process (GO:0006559) | 2.35565467 |
| 145 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35565467 |
| 146 | protein-lipid complex assembly (GO:0065005) | 2.35158122 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 2.33714813 |
| 148 | cholesterol efflux (GO:0033344) | 2.31750800 |
| 149 | acute-phase response (GO:0006953) | 2.31045883 |
| 150 | lipoprotein metabolic process (GO:0042157) | 2.30765420 |
| 151 | respiratory burst (GO:0045730) | 2.29520028 |
| 152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28992721 |
| 153 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.28715008 |
| 154 | apoptotic cell clearance (GO:0043277) | 2.27929818 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.27868792 |
| 156 | cytokine secretion (GO:0050663) | 2.27774028 |
| 157 | sulfur amino acid catabolic process (GO:0000098) | 2.27522427 |
| 158 | regulation of B cell differentiation (GO:0045577) | 2.27318512 |
| 159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.27150616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54755528 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.20686937 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.53988653 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22257741 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14080128 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05365567 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.01801251 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.80975488 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72404611 |
| 10 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58686316 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57165459 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56675606 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51404685 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50989438 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.50246746 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.43629465 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42380587 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26926042 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26818316 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20476052 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19638486 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14473896 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08217383 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02202142 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.98216169 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98098523 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88748121 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88086413 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86162546 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85387199 |
| 31 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79200147 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74278488 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73246945 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70129368 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69935170 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.64418994 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62352484 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.60685671 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60609268 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57469515 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55339776 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54353226 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53837452 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51587087 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.51344923 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.49469125 |
| 47 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.45835750 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43866788 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42395799 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40869085 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40781309 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40066439 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37565988 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35963226 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34458145 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33094703 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32278619 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31149034 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30693064 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29981010 |
| 61 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29823663 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28640408 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28359598 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27414634 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23537271 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21896234 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21623644 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20147350 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20059604 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18178439 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17129595 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15730634 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13818189 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13694397 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10081520 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09555300 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09488647 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09059942 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09047764 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07690251 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07560713 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05062252 |
| 83 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.04608799 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04063601 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02589905 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01822407 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00723123 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00584298 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00263558 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99953718 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99139915 |
| 92 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98647896 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98276737 |
| 94 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98155891 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98001001 |
| 96 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97958906 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96694288 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96691315 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96688104 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 0.96635002 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96211313 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95642643 |
| 103 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.95454728 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95173004 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94610286 |
| 106 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93263269 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92927744 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90032091 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88904147 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88420387 |
| 111 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87965777 |
| 112 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86952527 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86756161 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86291874 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85545415 |
| 116 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85448113 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85351378 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85082970 |
| 119 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84656883 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84513696 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82669881 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81743142 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81293138 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80615402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.26668139 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.12680790 |
| 3 | MP0005451_abnormal_body_composition | 2.79752876 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.75205294 |
| 5 | MP0009840_abnormal_foam_cell | 2.74129517 |
| 6 | MP0003436_decreased_susceptibility_to | 2.52521265 |
| 7 | MP0005365_abnormal_bile_salt | 2.40005817 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.36301755 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.36129490 |
| 10 | MP0003303_peritoneal_inflammation | 2.23327897 |
| 11 | MP0005387_immune_system_phenotype | 2.10946423 |
| 12 | MP0001790_abnormal_immune_system | 2.10946423 |
| 13 | MP0009785_altered_susceptibility_to | 2.08043281 |
| 14 | MP0000685_abnormal_immune_system | 2.04156334 |
| 15 | MP0001800_abnormal_humoral_immune | 2.00676385 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.99779941 |
| 17 | MP0005025_abnormal_response_to | 1.90797510 |
| 18 | MP0002419_abnormal_innate_immunity | 1.90283495 |
| 19 | MP0006082_CNS_inflammation | 1.83908267 |
| 20 | MP0003252_abnormal_bile_duct | 1.83850372 |
| 21 | MP0003724_increased_susceptibility_to | 1.82706676 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.82252289 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.80573534 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80239031 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.79508643 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.78614099 |
| 27 | MP0008260_abnormal_autophagy | 1.75793055 |
| 28 | MP0004947_skin_inflammation | 1.74480736 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.72679552 |
| 30 | MP0002723_abnormal_immune_serum | 1.66905015 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.65897230 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.62257101 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.61676017 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.58481578 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.55037718 |
| 36 | MP0009278_abnormal_bone_marrow | 1.54893888 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.54265202 |
| 38 | MP0000609_abnormal_liver_physiology | 1.53472554 |
| 39 | MP0005083_abnormal_biliary_tract | 1.51542259 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.50316538 |
| 41 | MP0001819_abnormal_immune_cell | 1.48670478 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.47248847 |
| 43 | MP0008469_abnormal_protein_level | 1.43350385 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.43252913 |
| 45 | MP0003075_altered_response_to | 1.42588321 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.38100385 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.37068120 |
| 48 | MP0001853_heart_inflammation | 1.35442254 |
| 49 | MP0005671_abnormal_response_to | 1.33204640 |
| 50 | MP0002405_respiratory_system_inflammati | 1.33033349 |
| 51 | MP0003091_abnormal_cell_migration | 1.32316811 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.32018344 |
| 53 | MP0009764_decreased_sensitivity_to | 1.29796622 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.29071214 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.27180956 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.27180956 |
| 57 | MP0002398_abnormal_bone_marrow | 1.26618344 |
| 58 | MP0010307_abnormal_tumor_latency | 1.26325446 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.26277513 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.24514038 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.24302682 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.23995841 |
| 63 | MP0000716_abnormal_immune_system | 1.23717949 |
| 64 | MP0004510_myositis | 1.22952674 |
| 65 | MP0005164_abnormal_response_to | 1.21409766 |
| 66 | MP0002254_reproductive_system_inflammat | 1.20386133 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.19129035 |
| 68 | MP0003448_altered_tumor_morphology | 1.17334641 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.17249161 |
| 70 | MP0002722_abnormal_immune_system | 1.13279073 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.10697696 |
| 72 | MP0002429_abnormal_blood_cell | 1.09396211 |
| 73 | MP0004883_abnormal_blood_vessel | 1.08217737 |
| 74 | MP0005023_abnormal_wound_healing | 1.08204559 |
| 75 | MP0009763_increased_sensitivity_to | 1.07437406 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.06606391 |
| 77 | MP0000598_abnormal_liver_morphology | 1.05476814 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.04806898 |
| 79 | MP0001873_stomach_inflammation | 1.04115984 |
| 80 | MP0000858_altered_metastatic_potential | 1.02756717 |
| 81 | MP0003186_abnormal_redox_activity | 1.02732031 |
| 82 | MP0002006_tumorigenesis | 1.01647678 |
| 83 | MP0002332_abnormal_exercise_endurance | 1.00405614 |
| 84 | MP0003866_abnormal_defecation | 1.00108099 |
| 85 | MP0001851_eye_inflammation | 0.97879549 |
| 86 | MP0008004_abnormal_stomach_pH | 0.97578381 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.97005759 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.96706454 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 0.96285225 |
| 90 | MP0004381_abnormal_hair_follicle | 0.95147614 |
| 91 | MP0005332_abnormal_amino_acid | 0.93971624 |
| 92 | MP0002132_abnormal_respiratory_system | 0.93921901 |
| 93 | MP0000343_altered_response_to | 0.92735935 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.92212770 |
| 95 | MP0002796_impaired_skin_barrier | 0.91373948 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.91225114 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.90869436 |
| 98 | MP0000490_abnormal_crypts_of | 0.86263633 |
| 99 | MP0005390_skeleton_phenotype | 0.84621940 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.84378160 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84335385 |
| 102 | MP0001849_ear_inflammation | 0.81966646 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.81406475 |
| 104 | MP0003045_fibrosis | 0.80935159 |
| 105 | MP0000604_amyloidosis | 0.80649085 |
| 106 | MP0005670_abnormal_white_adipose | 0.79663668 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.79403922 |
| 108 | MP0003690_abnormal_glial_cell | 0.77785216 |
| 109 | MP0001915_intracranial_hemorrhage | 0.77507286 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.77446872 |
| 111 | MP0003195_calcinosis | 0.76990709 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.76895960 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.76514777 |
| 114 | MP0005310_abnormal_salivary_gland | 0.75151159 |
| 115 | MP0000371_diluted_coat_color | 0.75035171 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.74548920 |
| 117 | MP0000249_abnormal_blood_vessel | 0.73981299 |
| 118 | MP0001663_abnormal_digestive_system | 0.71320778 |
| 119 | MP0006054_spinal_hemorrhage | 0.71173383 |
| 120 | MP0003828_pulmonary_edema | 0.70721029 |
| 121 | MP0005166_decreased_susceptibility_to | 0.69687319 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.69419017 |
| 123 | MP0004858_abnormal_nervous_system | 0.68997181 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.68996841 |
| 125 | MP0003795_abnormal_bone_structure | 0.67368781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 4.20484180 |
| 2 | Optic neuritis (HP:0100653) | 4.20484180 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.01985060 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.00672196 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.71050714 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.70653367 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.67720433 |
| 8 | Myocardial infarction (HP:0001658) | 3.46616236 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.37225467 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37209598 |
| 11 | Xanthomatosis (HP:0000991) | 3.29887763 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.26865748 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.22002381 |
| 14 | Joint hemorrhage (HP:0005261) | 3.21143949 |
| 15 | Increased IgE level (HP:0003212) | 3.17766911 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.13415432 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06392186 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06392186 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06392186 |
| 20 | Complement deficiency (HP:0004431) | 3.06335005 |
| 21 | Recurrent viral infections (HP:0004429) | 3.02562402 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.02164438 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.01068730 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.97158383 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.94094342 |
| 26 | Esophageal varix (HP:0002040) | 2.88999012 |
| 27 | Gingival bleeding (HP:0000225) | 2.85102812 |
| 28 | Pustule (HP:0200039) | 2.75834531 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.75810710 |
| 30 | Stomatitis (HP:0010280) | 2.74877379 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72379197 |
| 32 | Obstructive lung disease (HP:0006536) | 2.70590061 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70590061 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70269959 |
| 35 | Periodontitis (HP:0000704) | 2.62628007 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.61984346 |
| 37 | Recurrent skin infections (HP:0001581) | 2.61068558 |
| 38 | Hypobetalipoproteinemia (HP:0003563) | 2.60951915 |
| 39 | Abnormality of complement system (HP:0005339) | 2.60937669 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58509512 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57920573 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.57056185 |
| 43 | Loss of speech (HP:0002371) | 2.55156455 |
| 44 | Myositis (HP:0100614) | 2.54578534 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.51830598 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.50651533 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.46629409 |
| 48 | Encephalitis (HP:0002383) | 2.44672478 |
| 49 | Hyperlipoproteinemia (HP:0010980) | 2.44346352 |
| 50 | Cellulitis (HP:0100658) | 2.43342116 |
| 51 | Glomerulonephritis (HP:0000099) | 2.41144097 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.40762989 |
| 53 | Colitis (HP:0002583) | 2.39778637 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.37190032 |
| 55 | Gingivitis (HP:0000230) | 2.36611305 |
| 56 | Chronic otitis media (HP:0000389) | 2.36426605 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34919759 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.34385436 |
| 59 | Amyloidosis (HP:0011034) | 2.31224813 |
| 60 | Peritonitis (HP:0002586) | 2.31124169 |
| 61 | Vasculitis (HP:0002633) | 2.30258256 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30104028 |
| 63 | Hematochezia (HP:0002573) | 2.29908713 |
| 64 | Hypolipoproteinemia (HP:0010981) | 2.29781894 |
| 65 | Hemoptysis (HP:0002105) | 2.29115815 |
| 66 | Axonal loss (HP:0003447) | 2.28410195 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.28119135 |
| 68 | Epidermoid cyst (HP:0200040) | 2.26851301 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.26433804 |
| 70 | Orchitis (HP:0100796) | 2.25364988 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23997584 |
| 72 | Gangrene (HP:0100758) | 2.23219211 |
| 73 | Nasal polyposis (HP:0100582) | 2.20499209 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.17246124 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.16468794 |
| 76 | Nephritis (HP:0000123) | 2.16303647 |
| 77 | T lymphocytopenia (HP:0005403) | 2.14869997 |
| 78 | Epistaxis (HP:0000421) | 2.14292315 |
| 79 | Chest pain (HP:0100749) | 2.13930307 |
| 80 | Increased IgM level (HP:0003496) | 2.13734575 |
| 81 | Increased serum ferritin (HP:0003281) | 2.13347244 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.13014025 |
| 83 | Urticaria (HP:0001025) | 2.12735363 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.12542848 |
| 85 | Slow saccadic eye movements (HP:0000514) | 2.11795918 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.11781281 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11781281 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.10058316 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.09523683 |
| 90 | Osteomyelitis (HP:0002754) | 2.08823787 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.06937831 |
| 92 | Menorrhagia (HP:0000132) | 2.06878999 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.05604193 |
| 94 | Fat malabsorption (HP:0002630) | 2.05514760 |
| 95 | Tetraparesis (HP:0002273) | 2.05245233 |
| 96 | Arterial thrombosis (HP:0004420) | 2.05092480 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04957993 |
| 98 | Subacute progressive viral hepatitis (HP:0006572) | 2.03921945 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03385736 |
| 100 | Abnormality of T cell number (HP:0011839) | 2.03355886 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.03042515 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 2.02476228 |
| 103 | Hyperammonemia (HP:0001987) | 2.00347044 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.99931736 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.99931736 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99500928 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99500928 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99500928 |
| 109 | Viral hepatitis (HP:0006562) | 1.98944195 |
| 110 | Polycythemia (HP:0001901) | 1.98508914 |
| 111 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97704560 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.97350153 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.96665308 |
| 114 | Abnormal platelet function (HP:0011869) | 1.96665308 |
| 115 | Skin ulcer (HP:0200042) | 1.96578642 |
| 116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94450572 |
| 117 | Thrombophlebitis (HP:0004418) | 1.94218831 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.94181665 |
| 119 | Pulmonary embolism (HP:0002204) | 1.93963214 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92798148 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92798148 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.92796952 |
| 123 | Mitral stenosis (HP:0001718) | 1.92439404 |
| 124 | Glomerulopathy (HP:0100820) | 1.92422009 |
| 125 | Abnormality of the endocardium (HP:0004306) | 1.91213403 |
| 126 | Abnormality of purine metabolism (HP:0004352) | 1.90946410 |
| 127 | Emphysema (HP:0002097) | 1.90614837 |
| 128 | Nausea (HP:0002018) | 1.90415274 |
| 129 | Episodic fever (HP:0001954) | 1.89062882 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88187716 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.88187716 |
| 132 | Cheilitis (HP:0100825) | 1.87906388 |
| 133 | Abnormality of the pleura (HP:0002103) | 1.87268104 |
| 134 | Polygenic inheritance (HP:0010982) | 1.86550076 |
| 135 | Meningitis (HP:0001287) | 1.86183223 |
| 136 | Spastic diplegia (HP:0001264) | 1.85472129 |
| 137 | Recurrent bronchitis (HP:0002837) | 1.84728339 |
| 138 | Fatigue (HP:0012378) | 1.84582957 |
| 139 | Anorexia (HP:0002039) | 1.83701124 |
| 140 | Flat acetabular roof (HP:0003180) | 1.83581612 |
| 141 | Abnormality of the pericardium (HP:0001697) | 1.83089626 |
| 142 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82909166 |
| 143 | Disinhibition (HP:0000734) | 1.82705515 |
| 144 | Granulocytopenia (HP:0001913) | 1.81912981 |
| 145 | Abnormality of the intrinsic pathway (HP:0010989) | 1.81655941 |
| 146 | Purpura (HP:0000979) | 1.80802052 |
| 147 | Aseptic necrosis (HP:0010885) | 1.80471993 |
| 148 | IgM deficiency (HP:0002850) | 1.80234214 |
| 149 | Premature loss of primary teeth (HP:0006323) | 1.77796160 |
| 150 | Hepatosplenomegaly (HP:0001433) | 1.77726889 |
| 151 | Thin bony cortex (HP:0002753) | 1.75253119 |
| 152 | Leukocytosis (HP:0001974) | 1.73159485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.68225726 |
| 2 | PRPF4B | 3.23826281 |
| 3 | MAP4K1 | 3.07721554 |
| 4 | TYK2 | 2.98636657 |
| 5 | CDK12 | 2.59581739 |
| 6 | TBK1 | 2.41016108 |
| 7 | MAP3K14 | 2.36644439 |
| 8 | FGFR4 | 2.32794875 |
| 9 | MAP3K10 | 2.20359147 |
| 10 | STK10 | 2.17831705 |
| 11 | JAK3 | 2.08556456 |
| 12 | SMG1 | 2.07677199 |
| 13 | TRIB3 | 1.98048353 |
| 14 | IKBKE | 1.91441659 |
| 15 | PKN2 | 1.90046677 |
| 16 | TGFBR2 | 1.81903738 |
| 17 | BLK | 1.81354986 |
| 18 | IRAK3 | 1.73328753 |
| 19 | KIT | 1.69807777 |
| 20 | JAK1 | 1.69313278 |
| 21 | TAOK3 | 1.69111248 |
| 22 | FLT3 | 1.68582550 |
| 23 | TAOK2 | 1.67649989 |
| 24 | IKBKB | 1.61674982 |
| 25 | ZAP70 | 1.54078876 |
| 26 | TAOK1 | 1.53289547 |
| 27 | CSK | 1.53159723 |
| 28 | IRAK4 | 1.46804155 |
| 29 | RIPK1 | 1.46566395 |
| 30 | SIK1 | 1.43972165 |
| 31 | PTK6 | 1.41901377 |
| 32 | EPHB1 | 1.39513371 |
| 33 | GRK6 | 1.34808552 |
| 34 | MAP2K3 | 1.34701950 |
| 35 | ICK | 1.30676150 |
| 36 | EEF2K | 1.27991048 |
| 37 | MAP3K1 | 1.27103762 |
| 38 | FGFR3 | 1.26066244 |
| 39 | PIM1 | 1.24074553 |
| 40 | SIK3 | 1.22073263 |
| 41 | KSR2 | 1.21286127 |
| 42 | LRRK2 | 1.21005096 |
| 43 | RPS6KA4 | 1.19566946 |
| 44 | CSF1R | 1.19299075 |
| 45 | CDK6 | 1.13533070 |
| 46 | CHUK | 1.13010804 |
| 47 | BTK | 1.12224095 |
| 48 | BMPR2 | 1.11938848 |
| 49 | EPHA2 | 1.10262965 |
| 50 | KDR | 1.08885398 |
| 51 | CDC42BPA | 1.08231107 |
| 52 | NME2 | 1.07150835 |
| 53 | MAP3K13 | 1.05698261 |
| 54 | IRAK2 | 1.03423864 |
| 55 | CAMK1D | 1.02462170 |
| 56 | IRAK1 | 1.01949600 |
| 57 | MAP3K3 | 1.00663946 |
| 58 | JAK2 | 1.00646034 |
| 59 | HCK | 0.99529890 |
| 60 | STK3 | 0.99417160 |
| 61 | NEK9 | 0.94289763 |
| 62 | CDK4 | 0.93082215 |
| 63 | ITK | 0.91633214 |
| 64 | STK4 | 0.91458978 |
| 65 | FES | 0.90393506 |
| 66 | MST1R | 0.88941310 |
| 67 | SYK | 0.88705471 |
| 68 | TEC | 0.83983553 |
| 69 | MAPK11 | 0.82652205 |
| 70 | MST4 | 0.82498376 |
| 71 | BCKDK | 0.82478276 |
| 72 | MAP3K6 | 0.81685481 |
| 73 | TNK2 | 0.81585039 |
| 74 | LCK | 0.81561844 |
| 75 | PIM2 | 0.80662360 |
| 76 | EPHA3 | 0.79987249 |
| 77 | PDPK1 | 0.79668749 |
| 78 | MARK3 | 0.78788103 |
| 79 | HIPK2 | 0.76532796 |
| 80 | PRKD2 | 0.76517985 |
| 81 | MAP3K8 | 0.75598413 |
| 82 | RIPK4 | 0.75124239 |
| 83 | TXK | 0.74846020 |
| 84 | MATK | 0.72342251 |
| 85 | YES1 | 0.72087607 |
| 86 | TTN | 0.71429390 |
| 87 | BMX | 0.70408060 |
| 88 | MARK2 | 0.70319616 |
| 89 | PDK1 | 0.68636532 |
| 90 | RPS6KB2 | 0.67549719 |
| 91 | MAP3K2 | 0.66743825 |
| 92 | MOS | 0.66110773 |
| 93 | MTOR | 0.65447542 |
| 94 | NEK2 | 0.65317690 |
| 95 | GRK7 | 0.64488180 |
| 96 | LYN | 0.64142566 |
| 97 | EGFR | 0.63723699 |
| 98 | MAP3K5 | 0.61389745 |
| 99 | DDR2 | 0.61217511 |
| 100 | PAK4 | 0.60608195 |
| 101 | CDK9 | 0.60169037 |
| 102 | MAP3K11 | 0.58267135 |
| 103 | TESK2 | 0.56654714 |
| 104 | MELK | 0.54182727 |
| 105 | GSK3A | 0.53171343 |
| 106 | BRD4 | 0.52667283 |
| 107 | ABL1 | 0.50213648 |
| 108 | LATS1 | 0.49433109 |
| 109 | MET | 0.49034604 |
| 110 | TGFBR1 | 0.48810418 |
| 111 | MAP2K2 | 0.48413851 |
| 112 | FGR | 0.47433740 |
| 113 | PRKG2 | 0.46656887 |
| 114 | NLK | 0.46156868 |
| 115 | ALK | 0.45262089 |
| 116 | SCYL2 | 0.44629040 |
| 117 | CLK1 | 0.43776558 |
| 118 | SIK2 | 0.43387542 |
| 119 | RET | 0.42666013 |
| 120 | RPS6KL1 | 0.41931386 |
| 121 | RPS6KC1 | 0.41931386 |
| 122 | SGK3 | 0.41444760 |
| 123 | CAMK1G | 0.40878407 |
| 124 | PDGFRB | 0.39641788 |
| 125 | CDK7 | 0.39145649 |
| 126 | MAPK7 | 0.38619359 |
| 127 | TRPM7 | 0.38468930 |
| 128 | FRK | 0.38220017 |
| 129 | PBK | 0.35748512 |
| 130 | ABL2 | 0.35369879 |
| 131 | PRKAA2 | 0.34700354 |
| 132 | PTK2 | 0.34314676 |
| 133 | MAPKAPK2 | 0.33992229 |
| 134 | PDGFRA | 0.31372288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.97320236 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46373476 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.41829713 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31974129 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29688173 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97402184 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94518963 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89441850 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88183414 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78875899 |
| 11 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76625371 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74429459 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63059759 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55731667 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55621215 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.52013346 |
| 17 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45283027 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44691945 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43280870 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40586871 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.40222650 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.37634671 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30840124 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29188374 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28763919 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28645857 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28020214 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27353542 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26283887 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23823040 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23177643 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22872599 |
| 33 | * Influenza A_Homo sapiens_hsa05164 | 1.21482837 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20684966 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18919905 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17151784 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16500022 |
| 38 | Bladder cancer_Homo sapiens_hsa05219 | 1.15377977 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.14997256 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.14296422 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.14280360 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13520019 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11730740 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11636673 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11460752 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.10008667 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09590862 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.09176289 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.06849015 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03698102 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03526050 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.03459789 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.03245299 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 1.02657773 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.99448510 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99400600 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99362952 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98149018 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.98125743 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97115626 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96905537 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.96631758 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96212434 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94837193 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92062328 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91507724 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90311442 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89969820 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87766599 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87387814 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85941384 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85070480 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84439307 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82786944 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82478751 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82400912 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.82136020 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80006820 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.79335366 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77464261 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76585294 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74182366 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74005650 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.73370195 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73296598 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73218534 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.72833431 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71101939 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70805273 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.69968193 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69880953 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.68918939 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68901948 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68363905 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68146748 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67898177 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66793291 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66739863 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66375601 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65467656 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65388079 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64800490 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64545371 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.64533186 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64155121 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.63352900 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63315325 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63154504 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.61280245 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61042141 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59447620 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59175323 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58725032 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57957588 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57112900 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55842408 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54726816 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53335698 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53332230 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53068495 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52767692 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52376223 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51978469 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.51539356 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51151896 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50675059 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50487367 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50001917 |
| 129 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49858180 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49807390 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49692406 |
| 132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48530260 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48254352 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47939454 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47788989 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47276119 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.46860453 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46390956 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45606493 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41064590 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40729325 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38787211 |
| 143 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38287962 |
| 144 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38216839 |

